Navigation Links
American Society for Microbiology honors Deborah T. Hung
Date:6/8/2009

A 2009 American Society for Microbiology (ASM) Merck Irving S. Sigal Memorial Award is being presented to Deborah T. Hung, M.D., Ph.D., co-director of the Infectious Disease Initiative at the Broad Institute of MIT and Harvard, and assistant professor in the Department of Medicine at Harvard Medical School. Sponsored by Merck Research Laboratories, the Merck Irving S. Sigal Memorial Award is presented in memory of Irving S. Sigal, who was instrumental in the early discovery of therapies to treat HIV/AIDS, to recognize excellence in basic research in medical microbiology and infectious diseases.

Dr. Hung's research focused on the pathogenesis of Vibrio cholerae infection by using chemical genetics and small molecular screening to dissect essential steps in pathogenesis. She published her findingsa new small molecule inhibitor of Vibrio cholerae virulence and intestinal colonization, virstatin, which directly inhibited dimerization of the virulence transcriptional activator ToxTin 2005 in Science.

Currently, Dr. Hung's work focuses on tuberculosis (TB). She has already developed screens to identify small molecules that probe in vitro TB physiology and TB infection of macrophages. Her goal is to understand its persistent state by developing chemicals that can manipulate it and by identifying genes that are essential for it.

Dr. Hung received both her Ph.D. in Chemistry and her M.D. from Harvard. She completed her medical residency at Brigham and Women's Hospital, Boston, a clinical infectious disease fellowship at Brigham and Women's Hospital and the Massachusetts General Hospital, and a clinical fellowship in critical care medicine at Harvard.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... a United States multicenter, prospective clinical study that demonstrates the accuracy of ... capable of identifying clinically significant acute bacterial and viral respiratory tract infections ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... CA (PRWEB) , ... October ... ... a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today ... of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration ...
Breaking Biology Technology: